ARK Investment Management - ARCTURUS THERAPEUTICS LTD ownership

ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 23 filers reported holding ARCTURUS THERAPEUTICS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of ARCTURUS THERAPEUTICS LTD
ValueSharesWeighting
Q1 2019$6,332,000
+71.5%
927,144
+13.7%
0.18%
+20.7%
Q4 2018$3,693,000
-46.0%
815,176
+5.4%
0.15%
-27.5%
Q3 2018$6,840,000
+51.1%
773,772
+45.0%
0.21%
+24.7%
Q2 2018$4,526,000
+148.5%
533,773
+61.2%
0.17%
+84.4%
Q1 2018$1,821,000
+198.5%
331,165
+331.6%
0.09%
+83.7%
Q4 2017$610,00076,7370.05%
Other shareholders
ARCTURUS THERAPEUTICS LTD shareholders Q3 2018
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 72,805$330,0000.16%
ARK Investment Management 815,176$3,693,0000.15%
ROYCE & ASSOCIATES LP 106,436$482,0000.00%
Independence Bank of Kentucky 607$3,0000.00%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 27,300$124,0000.00%
GROUP ONE TRADING, L.P. 4,086$19,0000.00%
1832 Asset Management L.P. 560$3,0000.00%
CITIGROUP INC 171$1,0000.00%
MORGAN STANLEY 71,582$324,0000.00%
ACADIAN ASSET MANAGEMENT LLC 5,562$25,0000.00%
View complete list of ARCTURUS THERAPEUTICS LTD shareholders